Incidence of cancer of unknown primary in Sweden: Analysis by location of metastasis

European Journal of Cancer Prevention

Volumn 21, Issue 6, 2012, Pages 596-601

  Bevier, Melanie ^a   Sundquist, Jan ^b,c   Hemminki, Kari ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Age standardized incidence rate; Cancer of unknown primary; Incidence trend; Metastases in lymph nodes; Metastases in other specified organs

Indexed keywords

ANTIGEN;

ADULT; ARTICLE; BONE METASTASIS; CANCER INCIDENCE; CANCER LOCALIZATION; CANCER OF UNKNOWN PRIMARY SITE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DATA BASE; DIAGNOSTIC PROCEDURE; FEMALE; HEREDITY; HUMAN; IMAGING; KIDNEY CANCER; LIVER METASTASIS; LUNG CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; STANDARDIZATION; SWEDEN;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, UNKNOWN PRIMARY; PROGNOSIS; REGISTRIES; SWEDEN; YOUNG ADULT;

EID: 84866976266     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283523468     Document Type: Article

References (23)

1. Barlow L,Westergren K, Holmberg L, Talback M (2009). The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 48:27-33.
2. Barugel ME, Vargas C, Waltier GK (2009). Metastatic colorectal cancer: recent advances in its clinical management. Expert Rev Anticancer Ther 9: 1829-1847.
3. Blaszyk H, Hartmann A, Bjornsson J (2003). Cancer of unknown primary: clinicopathologic correlations. APMIS 111:1089-1094.
4. Bratt O, Berglund A, Adolfsson J, Johansson JE, Törnblom M, Stattin P, et al. (2010). Prostate cancer diagnosed after prostate-specific antigen testing of men without clinical signs of the disease: a population-based study from the National Prostate Cancer Register of Sweden. Scand J Urol Nephrol 44:384-390.
5. Coleman RE (2001). Metastatic bone disease: clinical features, pathophysiology and treatment strategies. Cancer Treat Rev 27:165-176.
6. Daugaard G (1994). Unknown primary tumors. Cancer Treat Rev 20:119-147.
7. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893-2917.
8. Hemminki K, Li X, Plna K, Granström C, Vaittinen P (2001). The nation-wide Swedish family-cancer database - updated structure and familial rates. Acta Oncol 40:772-777.
9. Hemminki K, Ji J, Brandt A, Mousavi SM, Sundquist J (2010). The Swedish Family-Cancer Database 2009: prospects for histology-specific and immigrant studies. Int J Cancer 126:2259-2267.
10. Hemminki K, Ji J, Sundquist J, Shu X (2011a). Familial risks in cancer of unknown primary: tracking the primary sites. J Clin Oncol 29:435-440.
11. Hemminki K, Liu H, Hemminki A, Sundquist J (2011b). Power and limits of modern cancer diagnostics: cancer of unknown primary. Ann Oncol 23: 760-764.
12. Keller ET, Zhang J, Cooper CR, Smith PC, McCauley LK, Pienta KJ, et al. (2001). Prostate carcinoma skeletal metastases: cross-talk between tumor and bone. Cancer Metastasis Rev 20:333-349.
13. Levi F, Te VC, Erler G, Randimbison L, Vecchia CL (2002). Epidemiology of unknown primary tumours. Eur J Cancer 38:1810-1812.
14. Mayordomo JI, Guerra JM, Guijarro C, Garcia-Prats MD, Gomez A, Lopez-Brea M, et al. (1993). Neoplasms of unknown primary site: a clinicopathological study of autopsied patients. Tumori 79:321-324.
15. Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin 55:74-108.
16. Pavlidis N, Fizazi K (2005). Cancer of unknown primary (CUP). Crit Rev Oncol Hematol 54:243-250.
17. Pavlidis N, Fizazi K (2009). Carcinoma of unknown primary (CUP). Crit Rev Oncol Hematol 69:271-278.
18. Pentheroudakis G, Briasoulis E, Pavlidis N (2007). Cancer of unknown primary site: missing primary or missing biology? Oncologist 12:418-425.
19. Randén M, Rutqvist LE, Johansson H (2009). Cancer patients without a known primary: incidence and survival trends in Sweden 1960-2007. Acta Oncol 48:915-920.
20. Segi M (1960). Cancer mortality for selected sites in 24 countries (1950-57). Sendai, Japan: Department of Public Health, Tohoku University of Medicine.
21. Shu X, Sundquist K, Sundquist J, Hemminki K (2011). Time trends in incidence, causes of death, and survival of cancer of unknown primary in Sweden. Eur J Cancer Prev [Epub ahead of print].
22. Smedby KE, Brandt L, Bäcklund ML, Blomqvist P (2009). Brain metastases admissions in Sweden between 1987 and 2006. Br J Cancer 101:1919-1924.
23. Van de Wouw AJ, Janssen-Heijnen MLG, Coebergh JWW, Hillen HFP (2002). Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands, 1984-1992. Eur J Cancer 38:409-413.